Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Staging and neuroprogression in bipolar disorder: a systematic review of the literature.

Gama CS, Kunz M, Magalhães PV, Kapczinski F.

Rev Bras Psiquiatr. 2013 Mar;35(1):70-4. Review.

2.

Biomarkers and staging of bipolar disorder: a systematic review.

Roda Â, Chendo I, Kunz M.

Trends Psychiatry Psychother. 2015 Jan-Mar;37(1):3-11. doi: 10.1590/2237-6089-2014-0002. Epub 2014 Dec 9. Review.

3.

Staging and neuroprogression in bipolar disorder.

Fries GR, Pfaffenseller B, Stertz L, Paz AV, Dargél AA, Kunz M, Kapczinski F.

Curr Psychiatry Rep. 2012 Dec;14(6):667-75. doi: 10.1007/s11920-012-0319-2. Review.

PMID:
23090632
4.

Staging bipolar disorder.

Vieta E, Reinares M, Rosa AR.

Neurotox Res. 2011 Feb;19(2):279-85. doi: 10.1007/s12640-010-9197-8. Epub 2010 May 12. Review.

PMID:
20461491
5.

[Bipolar disorder: staging and neuroprogression].

Rodrigues AA, Rosa AR, Kunz M, Bruna A, Kapczinski F.

Psychiatr Pol. 2014 Mar-Apr;48(2):231-43. Review. Polish.

PMID:
25016762
6.

Bipolar disorder: new perspectives in health care and prevention.

Leboyer M, Kupfer DJ.

J Clin Psychiatry. 2010 Dec;71(12):1689-95. doi: 10.4088/JCP.10m06347yel. Review.

7.

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.

Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS.

Neurosci Biobehav Rev. 2011 Jan;35(3):804-17. doi: 10.1016/j.neubiorev.2010.10.001. Epub 2010 Oct 8. Review.

PMID:
20934453
8.

From neuroprogression to neuroprotection: implications for clinical care.

Berk M, Conus P, Kapczinski F, Andreazza AC, Yücel M, Wood SJ, Pantelis C, Malhi GS, Dodd S, Bechdolf A, Amminger GP, Hickie IB, McGorry PD.

Med J Aust. 2010 Aug 16;193(4 Suppl):S36-40.

PMID:
20712560
9.

Neuroprogression and Cognitive Functioning in Bipolar Disorder: A Systematic Review.

Cardoso T, Bauer IE, Meyer TD, Kapczinski F, Soares JC.

Curr Psychiatry Rep. 2015 Sep;17(9):75. doi: 10.1007/s11920-015-0605-x. Review.

PMID:
26257147
10.

Stage managing bipolar disorder.

Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R, Conus P, Bechdolf A, Moylan S, Malhi GS.

Bipolar Disord. 2014 Aug;16(5):471-7. doi: 10.1111/bdi.12099. Epub 2013 Jun 20. Review.

11.

Novel biomarkers for bipolar disorder.

Teixeira AL, Barbosa IG, Machado-Vieira R, Rizzo LB, Wieck A, Bauer ME.

Expert Opin Med Diagn. 2013 Mar;7(2):147-59. doi: 10.1517/17530059.2013.734807. Epub 2012 Dec 16. Review.

PMID:
23530885
12.

Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report.

Kapczinski F, Magalhães PV, Balanzá-Martinez V, Dias VV, Frangou S, Gama CS, Gonzalez-Pinto A, Grande I, Ha K, Kauer-Sant'Anna M, Kunz M, Kupka R, Leboyer M, Lopez-Jaramillo C, Post RM, Rybakowski JK, Scott J, Strejilevitch S, Tohen M, Vazquez G, Yatham L, Vieta E, Berk M.

Acta Psychiatr Scand. 2014 Nov;130(5):354-63. doi: 10.1111/acps.12305. Epub 2014 Jun 25. Review.

PMID:
24961757
13.

Neuroimaging findings in late-onset schizophrenia and bipolar disorder.

Hahn C, Lim HK, Lee CU.

J Geriatr Psychiatry Neurol. 2014 Mar;27(1):56-62. doi: 10.1177/0891988713516544. Epub 2014 Jan 8. Review.

PMID:
24401535
14.

The potential use of biomarkers as an adjunctive tool for staging bipolar disorder.

Kapczinski F, Dias VV, Kauer-Sant'Anna M, Brietzke E, Vázquez GH, Vieta E, Berk M.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1366-71. doi: 10.1016/j.pnpbp.2009.07.027. Epub 2009 Aug 8.

PMID:
19666076
15.

Areas of controversy in neuroprogression in bipolar disorder.

Passos IC, Mwangi B, Vieta E, Berk M, Kapczinski F.

Acta Psychiatr Scand. 2016 Aug;134(2):91-103. doi: 10.1111/acps.12581. Epub 2016 Apr 21. Review.

PMID:
27097559
16.

The clinical implications of cognitive impairment and allostatic load in bipolar disorder.

Vieta E, Popovic D, Rosa AR, Solé B, Grande I, Frey BN, Martinez-Aran A, Sanchez-Moreno J, Balanzá-Martínez V, Tabarés-Seisdedos R, Kapczinski F.

Eur Psychiatry. 2013 Jan;28(1):21-9. doi: 10.1016/j.eurpsy.2011.11.007. Epub 2012 Apr 24. Review.

PMID:
22534552
17.

The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research.

Rizzo LB, Costa LG, Mansur RB, Swardfager W, Belangero SI, Grassi-Oliveira R, McIntyre RS, Bauer ME, Brietzke E.

Neurosci Biobehav Rev. 2014 May;42:157-69. doi: 10.1016/j.neubiorev.2014.02.004. Epub 2014 Feb 15. Review.

PMID:
24548785
18.

Treatments for late-life bipolar disorder.

Aziz R, Lorberg B, Tampi RR.

Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. Review.

PMID:
17296540
19.

Neuroprogression in bipolar disorder.

Schneider MR, DelBello MP, McNamara RK, Strakowski SM, Adler CM.

Bipolar Disord. 2012 Jun;14(4):356-74. doi: 10.1111/j.1399-5618.2012.01024.x. Review.

PMID:
22631620
20.

Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder.

Walz JC, Andreazza AC, Frey BN, Cacilhas AA, Ceresér KM, Cunha AB, Weyne F, Stertz L, Santin A, Gonçalves CA, Kapczinski F.

Neurosci Lett. 2007 Mar 19;415(1):87-9. Epub 2007 Jan 17.

PMID:
17234344
Items per page

Supplemental Content

Write to the Help Desk